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Objectives/purpose: Cancer follow-up care is moving away from routine, consultant-led models to 
patient-initiated models of care incorporating supported self-management. A qualitative evaluation 
of a nurse-led supported early discharge follow-up service for breast cancer patients was conducted 
to explore how services could be optimised. 
Methods: 150 women with breast cancer on a supported early discharge follow-up regimen were 
recruited as part of a mixed methods study from two UK hospitals. Telephone interviews were 
conducted with a maximum variation subsample (n=20). Thematic analysis was conducted.   
Results: The majority described positive views towards being on supported early discharge follow-
up. A significant proportion, however, reported unmet needs and struggled with navigating 
uncertainties, related to accessing ongoing care and support, performing breast self-examination, 
managing ongoing side-effects, future care pathways and recurrence risk. Seven themes emerged 
relating to women’s varying experiences of supported early discharge; empowerment over health 
and wellbeing; confidence in monitoring for cancer recurrence; perceptions of open access 
healthcare as a ‘safety net’; the role of primary care; preparedness and support for managing 
ongoing treatment side-effects; the role and timing of holistic needs assessments (HNAs)/living well 
courses; influences on managing fear of recurrence.  
Conclusion and Clinical implications: Findings indicate how self-management support and 
information provided could be further optimised through targeted provision of psychological 
support and reassurance, more timely access to HNAs, personalised recurrence risk information, 
greater education on breast self-examination and how to recognise a recurrence, and clearer 
signposting to support for ongoing side-effects. Ehealth interventions might be useful tools 
warranting future investigation.   
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